Upcoming Events

Today
This Week

Events

Understanding Hematopoiesis in Crohn’s Disease: From Bedside to Bench

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research
Louis Cohen, M.D., associate professor, Department of Medicine, Division of Gastroenterology Icahn School of Medicine at Mount Sinai

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research
Jacob Donoghue, M.D., Ph.D., CEO & Co-Founder, Beacon Biosignals

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Title TBA

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Seminars in Clinical Research

Upcoming Events

22nd Annual Tri-Institutional Chemical Biology Symposium

| CASPARY AUDITORIUM

Understanding Hematopoiesis in Crohn’s Disease: From Bedside to Bench

| CARSON FAMILY AUDITORIUM (CRC)

The Impact of Early Life Adversity on Developing Emotion Circuits

| CARSON FAMILY AUDITORIUM (CRC)

News

A new approach to medical technology development emphasizes global access from the outset

A toolkit devised by Rockefeller scientists works toward reducing global health disparities by factoring access and affordability into the earliest stages of biomedical discovery.

Mapping gene expression and epigenetic changes that cause "undead" cancer cells to trigger cancer-promoting inflammation

Researchers show how the senescent state induced by sarcoma and breast cancer drugs drives inflammation.

How studying RNA regulation in the brain illuminates mysteries ranging from the birth of language to treating Parkinsons

Thirty years ago, an insight from a rare brain disease took Robert Darnell's career in an unexpected direction. He’s still surprised by what he’s learning.